
Scott Long
Examiner (ID: 7374, Phone: (571)272-9048 , Office: P/1633 )
| Most Active Art Unit | 1633 |
| Art Unit(s) | 1633 |
| Total Applications | 882 |
| Issued Applications | 557 |
| Pending Applications | 29 |
| Abandoned Applications | 301 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6295157
[patent_doc_number] => 20100160208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-24
[patent_title] => 'Pharmaceutical composition'
[patent_app_type] => utility
[patent_app_number] => 12/585086
[patent_app_country] => US
[patent_app_date] => 2009-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 21629
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20100160208.pdf
[firstpage_image] =>[orig_patent_app_number] => 12585086
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/585086 | Pharmaceutical composition | Sep 1, 2009 | Abandoned |
Array
(
[id] => 6624829
[patent_doc_number] => 20100034790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-11
[patent_title] => 'Use of materials for treatment of central nervous system lesions'
[patent_app_type] => utility
[patent_app_number] => 12/462143
[patent_app_country] => US
[patent_app_date] => 2009-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 21797
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20100034790.pdf
[firstpage_image] =>[orig_patent_app_number] => 12462143
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/462143 | Use of materials for treatment of central nervous system lesions | Jul 29, 2009 | Issued |
Array
(
[id] => 8128583
[patent_doc_number] => 20120088842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-12
[patent_title] => 'METHODS FOR OPTIMIZING ELECTROPORATION'
[patent_app_type] => utility
[patent_app_number] => 13/147165
[patent_app_country] => US
[patent_app_date] => 2009-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9202
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20120088842.pdf
[firstpage_image] =>[orig_patent_app_number] => 13147165
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/147165 | METHODS FOR OPTIMIZING ELECTROPORATION | Jul 14, 2009 | Abandoned |
Array
(
[id] => 6131870
[patent_doc_number] => 20110088106
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-14
[patent_title] => 'COMPOSITIONS AND METHODS FOR MEDIATING CELL CYCLE PROGRESSION'
[patent_app_type] => utility
[patent_app_number] => 12/503001
[patent_app_country] => US
[patent_app_date] => 2009-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 24985
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20110088106.pdf
[firstpage_image] =>[orig_patent_app_number] => 12503001
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/503001 | COMPOSITIONS AND METHODS FOR MEDIATING CELL CYCLE PROGRESSION | Jul 13, 2009 | Abandoned |
Array
(
[id] => 6496772
[patent_doc_number] => 20100010099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-14
[patent_title] => 'MEDIUM AND DEVICE FOR PROLIFERATION OF STEM CELLS AND TREATMENT OF CANCER-RELATED STEM CELL WITH RESVERATROL'
[patent_app_type] => utility
[patent_app_number] => 12/501279
[patent_app_country] => US
[patent_app_date] => 2009-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 14840
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20100010099.pdf
[firstpage_image] =>[orig_patent_app_number] => 12501279
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/501279 | Medium and device for proliferation of stem cells and treatment of cancer-related stem cell with resveratrol | Jul 9, 2009 | Issued |
Array
(
[id] => 6326274
[patent_doc_number] => 20100197509
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'Novel oligonucleotide arrays and their use for sorting, isolating, sequencing, and manipulating nucleic acids'
[patent_app_type] => utility
[patent_app_number] => 12/498267
[patent_app_country] => US
[patent_app_date] => 2009-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 51
[patent_no_of_words] => 58880
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20100197509.pdf
[firstpage_image] =>[orig_patent_app_number] => 12498267
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/498267 | Novel oligonucleotide arrays and their use for sorting, isolating, sequencing, and manipulating nucleic acids | Jul 5, 2009 | Abandoned |
Array
(
[id] => 6159932
[patent_doc_number] => 20110159070
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-30
[patent_title] => 'BIOMATERIALS AND IMPLANTS FOR ENHANCED CARTILAGE FORMATION, AND METHODS FOR MAKING AND USING THEM'
[patent_app_type] => utility
[patent_app_number] => 12/997689
[patent_app_country] => US
[patent_app_date] => 2009-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 20139
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20110159070.pdf
[firstpage_image] =>[orig_patent_app_number] => 12997689
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/997689 | BIOMATERIALS AND IMPLANTS FOR ENHANCED CARTILAGE FORMATION, AND METHODS FOR MAKING AND USING THEM | Jul 1, 2009 | Abandoned |
Array
(
[id] => 6303745
[patent_doc_number] => 20100162419
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-24
[patent_title] => 'TUMOR-INITIATING CELLS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 12/495417
[patent_app_country] => US
[patent_app_date] => 2009-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 37389
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 35
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20100162419.pdf
[firstpage_image] =>[orig_patent_app_number] => 12495417
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/495417 | Tumor-initiating cells and methods of use | Jun 29, 2009 | Issued |
Array
(
[id] => 6033508
[patent_doc_number] => 20110082191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-07
[patent_title] => 'METHOD FOR TREATING OR PREVENTING RADIATION DAMAGE BY IN VIVO GENE THERAPY'
[patent_app_type] => utility
[patent_app_number] => 12/999403
[patent_app_country] => US
[patent_app_date] => 2009-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12296
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20110082191.pdf
[firstpage_image] =>[orig_patent_app_number] => 12999403
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/999403 | METHOD FOR TREATING OR PREVENTING RADIATION DAMAGE BY IN VIVO GENE THERAPY | Jun 25, 2009 | Abandoned |
Array
(
[id] => 6417539
[patent_doc_number] => 20100167286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'Pluripotent cell lines and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/459019
[patent_app_country] => US
[patent_app_date] => 2009-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 25721
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20100167286.pdf
[firstpage_image] =>[orig_patent_app_number] => 12459019
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/459019 | Pluripotent cell lines and methods of use thereof | Jun 23, 2009 | Issued |
Array
(
[id] => 5495860
[patent_doc_number] => 20090263888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-22
[patent_title] => 'KOJI MOLD-ORIGIN PHOSPHOLIPASE A2'
[patent_app_type] => utility
[patent_app_number] => 12/489827
[patent_app_country] => US
[patent_app_date] => 2009-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9352
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20090263888.pdf
[firstpage_image] =>[orig_patent_app_number] => 12489827
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/489827 | Koji mold-origin phospholipase A2 | Jun 22, 2009 | Issued |
Array
(
[id] => 5397841
[patent_doc_number] => 20090317904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'VCP-Based Vectors for Algal Cell Transformation'
[patent_app_type] => utility
[patent_app_number] => 12/480635
[patent_app_country] => US
[patent_app_date] => 2009-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 2704
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20090317904.pdf
[firstpage_image] =>[orig_patent_app_number] => 12480635
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/480635 | VCP-based vectors for algal cell transformation | Jun 7, 2009 | Issued |
Array
(
[id] => 6333979
[patent_doc_number] => 20100115642
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'Xenogenic immune system in a non-human mammal'
[patent_app_type] => utility
[patent_app_number] => 12/455633
[patent_app_country] => US
[patent_app_date] => 2009-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6857
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20100115642.pdf
[firstpage_image] =>[orig_patent_app_number] => 12455633
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/455633 | Xenogenic immune system in a non-human mammal | Jun 2, 2009 | Abandoned |
Array
(
[id] => 6630256
[patent_doc_number] => 20100004323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-07
[patent_title] => 'PROMOTER CONSTRUCT'
[patent_app_type] => utility
[patent_app_number] => 12/475943
[patent_app_country] => US
[patent_app_date] => 2009-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 16537
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12475943
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/475943 | PROMOTER CONSTRUCT | May 31, 2009 | Abandoned |
Array
(
[id] => 8577554
[patent_doc_number] => 08343765
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-01
[patent_title] => 'Gene injection apparatus and gene injection method'
[patent_app_type] => utility
[patent_app_number] => 12/475023
[patent_app_country] => US
[patent_app_date] => 2009-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 18
[patent_no_of_words] => 4471
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12475023
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/475023 | Gene injection apparatus and gene injection method | May 28, 2009 | Issued |
Array
(
[id] => 9153185
[patent_doc_number] => 08586086
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-11-19
[patent_title] => 'Hydrogel capable of containing and conveying cells'
[patent_app_type] => utility
[patent_app_number] => 12/994873
[patent_app_country] => US
[patent_app_date] => 2009-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7730
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12994873
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/994873 | Hydrogel capable of containing and conveying cells | May 28, 2009 | Issued |
Array
(
[id] => 7773071
[patent_doc_number] => 08119156
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-02-21
[patent_title] => 'Dual action, inhaled formulations providing both an immediate and sustained release profile'
[patent_app_type] => utility
[patent_app_number] => 12/437765
[patent_app_country] => US
[patent_app_date] => 2009-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16305
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/119/08119156.pdf
[firstpage_image] =>[orig_patent_app_number] => 12437765
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/437765 | Dual action, inhaled formulations providing both an immediate and sustained release profile | May 7, 2009 | Issued |
Array
(
[id] => 6320699
[patent_doc_number] => 20100196407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'TICK GALECTIN'
[patent_app_type] => utility
[patent_app_number] => 12/426999
[patent_app_country] => US
[patent_app_date] => 2009-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8636
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20100196407.pdf
[firstpage_image] =>[orig_patent_app_number] => 12426999
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/426999 | Tick galectin | Apr 20, 2009 | Issued |
Array
(
[id] => 6174020
[patent_doc_number] => 20110177023
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-21
[patent_title] => 'GENETICALLY MODIFIED HUMAN UMBILICAL CORD PERIVASCULAR CELLS FOR PROPHYLAXIS AGAINST OR TREATMENT OF BIOLOGICAL OR CHEMICAL AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/988909
[patent_app_country] => US
[patent_app_date] => 2009-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11447
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20110177023.pdf
[firstpage_image] =>[orig_patent_app_number] => 12988909
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/988909 | Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents | Apr 19, 2009 | Issued |
Array
(
[id] => 5487100
[patent_doc_number] => 20090276865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'Transgenic Drosophila line having fluorescent proteins with different colors'
[patent_app_type] => utility
[patent_app_number] => 12/385726
[patent_app_country] => US
[patent_app_date] => 2009-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5452
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0276/20090276865.pdf
[firstpage_image] =>[orig_patent_app_number] => 12385726
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/385726 | Transgenic Drosophila line having fluorescent proteins with different colors | Apr 16, 2009 | Abandoned |